Profit From Intel Corporation (INTC)’s Colossal Failure

Page 1 of 2

Normally, when a business delivers results that fail to meet investors’ expectations, it is due to poor financial performance.  Today, I believe I have found the exact opposite situation: a business that will miss expectations by continuing to survive and thrive but is currently priced to fail.   Wall Street and the average investor seem to believe that Intel Corporation (NASDAQ:INTC) will be going out of business in about five years. I believe that Intel Corporation (NASDAQ:INTC) will miss that projection by a wide margin.

Intel Corporation (INTC)Intel Corporation (NASDAQ:INTC) dominates the market for the processors that drive our computers.  It only has one real competitor in that space, Advanced Micro Devices, Inc. (NYSE:AMD) — and to refer to AMD as a real competitor to Intel Corporation (NASDAQ:INTC) takes quite a stretch.  A quick check of Yahoo! Finance lists Texas Instruments Incorporated (NASDAQ:TXN) as a direct competitor of Intel Corporation (NASDAQ:INTC) as well.

The reason I believe it is such a stretch to call AMD a real competitor to Intel Corporation (NASDAQ:INTC) is that its business can most kindly be described as a basket case.

It is projected to lose $221.34 million in the current fiscal year, ending Dec. 31, and an additional $35.7 million next year!  It has a current debt to equity ratio of 3.8 to 1, and given the projections for this year, that will get worse.  With current shareholder equity of only $538 million, these projections would equate to a loss of 41% of total equity in 2013 alone!  It would border on insanity to consider this business a real competitor to a cash-gushing giant like Intel Corporation (NASDAQ:INTC).

Is Intel really priced to fail?

It is hard to believe that anyone believes Intel is going out of business, but, a dispassionate analysis of the numbers seems to indicate that is the current sentiment on Wall Street.

Last year, Intel generated cash from operations of almost $18.9 billion, against a current market cap (less cash on hand) of $95 billion.  This means that minus its existing cash hoard, this business is priced at 5.03 times its cash-generating capability.  Even when considering the substantial capital expenditures Intel makes in order to maintain its dominant position, it maintains a multiple of 10.5 times free cash flow when a five-year average of capital expenditures is applied.  This is simply an absurdly cheap valuation for a business that has no real competition in its primary business and generates almost $19 billion/year in cash flow.

Valuation: Intel Versus the Competition

INTC               TXN                AMD

P/E Current                             9.83                 22.7                 -1.61

P/E Forward                            9.97                 15.66               -51.2

Proj. 5-Yr. Earnings Grwth.      9.7%                 8.3%               10.2%

Debt to Equity                          0                     0.52                 3.8

Gross Margin 5-Year              60.7%               50.2%               39.5%

Net Margin 5-Year                 20.2%               16.7%               -8.0%

ROA 5-yr. average                14.6%               14.3%               -6.9%

ROE 5-yr. average                20.2%               20.6%              -45.8%

ROC 5-yr. average                17.3%               16.9%              -10.2%

As these numbers reveal, Intel is performing financially much like Texas Instruments, but is priced much closer to the valuations assigned to Advanced Mirco Devices.  If Intel were to simply be assigned a market value based on a P/E ratio equal to Texas Instruments, shareholders would be rewarded by with a 50% return on investment.

Is there any rational explanation for this discrepancy?  Well, Wall Street dislikes Intel at the moment because it’s been late to the party in the chip market for mobile devices, currently dominated by QUALCOMM, Inc. (NASDAQ:QCOM) .

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!